Dead End Read Free Page B

he’d imagined. There was more makeup, too, mascara and eye shadow: Parnell preferred her without either.
    He smiled and said: ‘Hi again. What did you win?’
    She didn’t reply, stopping to look down at him, as she had the day of the supposed bet. ‘No one told you? Bastards!’
    â€˜Told me what?’
    â€˜Grant’s addressing us. He always does.’
    â€˜I was told.’
    â€˜There’s a dress code. He likes formality.’
    Parnell looked down at his sweatshirt, jeans and loafers before coming back up to her. ‘You are joking, aren’t you – about it being important how we’re dressed?’
    â€˜No.’
    â€˜I think it’s funny, even if you don’t. Anything that stupid has got to be funny.’
    â€˜I don’t think it’s funny.’
    â€˜I’ll hide myself in the crowd,’ promised Parnell.
    But he couldn’t. The seats were designated and his was in the second row, directly in front of an already emplaced podium on a higher dais. Behind the podium were seats for the parent-company directors and the chief executives from Dubette’s overseas divisions. Parnell was aware of the attention and the frowns of those around him as he edged along his reserved line to his assigned place.
    Parnell sensed the stir and rose with everyone else at the entry of the governing directors on to the raised area, led by Edward C. Grant. The president was a small, bull-chested man, the whiteness of his hair heightened by a deep tan. The man made his way across the stage with the confidence of someone who knew seas would part if he demanded it. He wore a dark blue suit that Parnell realized had been copied by virtually everyone surrounding him. Parnell’s sweatshirt was yellow and he accepted that he stood out like a beacon. Being 6'2" made him even more of a lighthouse among his smaller neighbours. When the president came to the podium for his keynote address, Parnell at once became Grant’s unremitting focus. Parnell stared back unperturbed. He’d heard of commercial companies ruled like medieval fiefdoms, but always imagined the stories exaggerated by those in pure research, to reassure themselves they were right to remain aloof in cosseted scientific academia.
    The past year had been more successful than that preceding it, opened Grant. There had been a 20 per cent increase in after-tax profits, which he was later that month going to announce to the stockholders, with a recommendation for an overall salary increase. The excellence of the research division gave every expectation of new or improved drugs being introduced into the marketplace: medical breakthroughs even. They could not, however, relax. Competition was intense and would remain so: increase even. Turning to acknowledge one of the men assembled behind him, Grant said there had been, from their French subsidiary, a suggestion how to thwart reverse-analyses of their more successful drugs. It was essential to guard against that, from their competitors, as it was against their products being pirated by such analyses, particularly by Third World countries pleading poverty as an excuse for manufacturing their own cheaper versions from published formulae, denying companies like themselves the profits essential to recover their huge and continuing research expenditure. During the past year Dubette had initiated twenty-three patent and copyright infringement actions in ten countries, and so far had succeeded in fifteen, with every confidence of the remaining eight being adjudged in their favour. Although too large and too diverse properly to fit the description, Grant nevertheless considered Dubette a family structure, people working together, pulling together, according to a strictly observed set of understandings, like a united, cohesive household. Parnell went through the motions of clapping, along with everyone else, and thought that the individual presentations from chief